Thank you, that is very helpful.

Jacki

-----Original Message-----
From: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org> On Behalf Of Bobbie Ursin
Sent: Tuesday, August 10, 2021 10:33 AM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] Re: Subaward Project Period vs budget period

* External Email - Caution *

Jacki,

If you use the FDP template, it allows you to enter both the performance period & the budget period, then you can specify when the subrecipient's contract period ends.  Usually this is the performance period end date.  You can also indicate the dollar amount currently being authorized & the total anticipated amount for cumulative later year authorizations.

Bobbie Ursin - semi retired
Southern Utah University

________________________________________
From: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org> on behalf of Mallmann, Jacquelyn <xxxxxx@wustl.edu>
Sent: Monday, August 9, 2021 2:20:31 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] Subaward Project Period vs budget period

Hi Research Administrators,

Does anyone know where I can find uniform guidance/NIH policy on subaward contract effective dates?  Are subawardees bound by the project period of the NOA (4 or 5 years for most R01s), or by the annual budget dates, at which time we issue a modification to extend the subaward for another year?

ISSUE: most years we do not receive the next year's NOA before the end date of the current budget year, so the questions is, are we out of contract each year while waiting for the next year's NOA? The subawards are for the performance sites of an ongoing clinical trial and there is concern that the data might be compromised if it was collected during the time we were waiting for the next NOA and the modification to be executed, if we are not considered to be under contract.

It certainly would not be practical to stop the trial for 3-6 months/year, or longer, while waiting for NOA and then the process of getting them executed (not always unilateral).  We have about 40 subcontracts on one trial with almost half being international.

Thanks for any guidance you can provide!

Jacki
Jacki Mallmann
Sr. Grant Specialist

CONTACT INFO:
DIAN-TU, Department of Neurology
Washington University School of Medicine
4488 Forest Park Ave, Ste. 301
CB 8111
St. Louis, MO 63108
Office phone: 314.362.7352
Cell phone:  314.607.3429

________________________________
The materials in this message are private and may contain Protected Healthcare Information or other information of a sensitive nature. If you are not the intended recipient, be advised that any unauthorized use, disclosure, copying or the taking of any action in reliance on the contents of this information is strictly prohibited. If you have received this email in error, please immediately notify the sender via telephone or return mail.

- = - = - = - = - = - = -

To unsubscribe from RESADM-L, click here: http://archives.simplelists.com

List archives are available at: https://lists.healthresearch.org/resadm-l

To change your settings: https://lists.healthresearch.org

- = - = - = - = - = - = -

To unsubscribe from RESADM-L, go to https://lists.healthresearch.org and go into the Account Settings area.

List archives are available at:  https://lists.healthresearch.org/resadm-l

To change your settings (such as Digest Mode or to temporarily suspend list emails):   https://lists.healthresearch.org

________________________________
The materials in this message are private and may contain Protected Healthcare Information or other information of a sensitive nature. If you are not the intended recipient, be advised that any unauthorized use, disclosure, copying or the taking of any action in reliance on the contents of this information is strictly prohibited. If you have received this email in error, please immediately notify the sender via telephone or return mail.